Tag Archives: Promazine

Lamotrigine: 25mg, 50mg, 100mg, 150mg, 200mg, 250mg. Uses and Administration

Lamotrigine, a phenyltriazine compound, is an antiepileptic used mainly for monotherapy or adjunctive treatment of partial seizures and primary and secondarily generalised tonic-clonic seizures. It may be used for seizures associated with the Lennox-Gastaut syndrome and for the maintenance treatment of bipolar disorder. The doses given below for the use of lamotrigine in epilepsy are… Read More »

Carbamazepine: 100mg, 200mg, 300mg, 400mg. Uses and Administration

Carbamazepine is a dibenzazepine derivative with antiepileptic and psychotropic properties. It is used to control secondarily generalised tonic-clonic seizures and partial seizures, and in some primary generalised seizures. Carbamazepine is also used in the treatment of trigeminal neuralgia and has been tried with variable success in glossopharyngeal neuralgia and other severe pain syndromes associated with… Read More »

Schizophrenia: Atypical Antipsychotics

Many atypical antipsychotics are available. In addition to those reviewed in the following sections, atypical agents include perospirone (Sumitomo’s Lullan) and zotepine (Fujisawa’s Lodopin, Aventis’s Nipolept, Orion Pharma’ s Zoleptil, generics). These drugs are not discussed in detail here because their mechanisms of action are similar to those of other atypical agents, they are launched… Read More »

Drug Treatment Of Mania

When assessing the patient, enquiries should be made about their recent compliance with medication, as sudden discontinuation of lithium may have triggered the manic episode. It is usually prudent to cease any antidepressant medication they may have been taking. A physical examination and tests of the blood and urine should, if possible, precede drug treatment… Read More »

Pharmacotherapy in the Treatment of People With Schizophrenia

The pharmacological agents most primarily associated with treatment of schizophrenia are grouped in a large and heterogeneous family, the antipsychotics. Recently, this family has been subdivided into the typicals, or neuroleptics, and the atypicals (see Tables Selected Typical Antipsychotic Drugs and Their Characteristics and Atypical Antipsychotics: Relative Potencies and Side Effects). The neuroleptics are so… Read More »

Adjunctive Pharmacotherapy and Related Issues

Managing antipsychotic side effects. Antipsychotic drugs produce problematic side effects in many individuals (see Table Side Effects of Typical Antipsychotic Drugs). A major category of side effects results from neurotransmitter dysregulation of the extra-pyramidal motor system. It is thought that these side effects are the result of an imbalance of dopaminergic and acetylcholinergic activity in… Read More »

Psychotic Disorders in Children: Clinical Use of Antipsychotic Medications

Considerations in the Clinical Use of Antipsychotic Medications The following assertions summarize the issues discussed in this post: • Antipsychotic medications are key components in the comprehensive treatment program of severely mood dysregulated children and adolescents with psychotic symptoms, and for children and adolescents with psychotic disorders. • The second generation antipsychotics seem to offer… Read More »

Introduction To Atypical Antipsychotics

This section deals specifically with the use of atypical antipsychotics currently in use in the United States. In less than a decade, atypical antipsychotics have become the dominant force in the treatment of adult and childhood psychosis. As a result of this rapid change, the typical antipsychotics have been progressively relegated to the sidelines of… Read More »

Are Atypical Antipsychotics Better Than Conventional Antipsychotics?

Food and Drug Administration regulatory procedures assure that drugs approved for the treatment of schizophrenia have documentation of efficacy. What follows is complicated. The physician must decide which drug, at what dose, in what combination, for what period of time, for which aspect of illness, whether to use off-label and at what risk and cost.… Read More »

Clinical Use of Antipsychotic Medications: Medication Monitoring

Vinks and Walsons (2003) indications for therapeutic drug monitoring are listed in TABLE Factors to Attend to in Medication Monitoring. TABLE Factors to Attend to in Medication Monitoring Inadequate response Higher than standard dose required Serious and persistent side effects Suspected toxicity Suspected noncompliance Suspected drug-drug interactions New preparations, changing brands Emerging illnesses Presence of… Read More »